Combivent



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Chronic Obstructive Pulmonary Disease 47.0%
Asthma 13.9%
Hypertension 9.8%
Emphysema 6.0%
Blood Cholesterol Increased 3.2%
Dyspnoea 2.7%
Anxiety 2.0%
Diabetes Mellitus 1.6%
Gastrooesophageal Reflux Disease 1.6%
Hypothyroidism 1.3%
Product Used For Unknown Indication 1.3%
Cardiac Disorder 1.3%
Bronchitis Chronic 1.3%
Depression 1.2%
Prophylaxis 1.1%
Bronchitis 1.1%
Back Pain 1.0%
Supplementation Therapy 0.9%
Cardiac Failure Congestive 0.9%
Hypersensitivity 0.8%
Drug Ineffective 19.5%
Dyspnoea 13.4%
Off Label Use 12.8%
Product Quality Issue 9.4%
Dysgeusia 6.5%
Overdose 4.6%
Pneumonia 4.3%
Wheezing 3.9%
Drug Prescribing Error 3.8%
Throat Irritation 3.5%
Prescribed Overdose 3.4%
Drug Effect Decreased 2.7%
Death 1.9%
Tremor 1.7%
Pulmonary Congestion 1.6%
Retching 1.6%
Cough 1.4%
Oropharyngeal Pain 1.4%
Therapeutic Response Decreased 1.4%
Chronic Obstructive Pulmonary Disease 1.3%
Secondary
Chronic Obstructive Pulmonary Disease 42.1%
Asthma 14.8%
Emphysema 9.2%
Hypertension 6.4%
Product Used For Unknown Indication 4.7%
Dyspnoea 3.8%
Blood Cholesterol Increased 2.5%
Bronchitis 2.2%
Drug Use For Unknown Indication 2.1%
Bronchitis Chronic 1.9%
Gastrooesophageal Reflux Disease 1.5%
Hypothyroidism 1.5%
Anxiety 1.3%
Atrial Fibrillation 1.3%
Diabetes Mellitus 0.9%
Cough 0.9%
Depression 0.9%
Fluid Retention 0.7%
Hypersensitivity 0.7%
Arthritis 0.6%
Drug Ineffective 15.9%
Dyspnoea 15.0%
Off Label Use 11.8%
Product Quality Issue 9.2%
Pneumonia 7.2%
Overdose 6.0%
Wheezing 5.5%
Tremor 3.1%
Throat Irritation 2.9%
Chronic Obstructive Pulmonary Disease 2.5%
Death 2.5%
Prescribed Overdose 2.5%
Pulmonary Congestion 2.3%
Vision Blurred 2.3%
Mesothelioma 2.0%
Vomiting 2.0%
Drug Effect Decreased 1.9%
Dysgeusia 1.8%
Lung Infection 1.8%
Oropharyngeal Pain 1.8%
Concomitant
Product Used For Unknown Indication 21.4%
Drug Use For Unknown Indication 14.5%
Chronic Obstructive Pulmonary Disease 13.4%
Asthma 11.1%
Hypertension 5.4%
Pain 4.4%
Dyspnoea 3.3%
Depression 3.3%
Emphysema 3.2%
Smoking Cessation Therapy 2.4%
Diabetes Mellitus 2.3%
Gastrooesophageal Reflux Disease 2.3%
Rheumatoid Arthritis 2.2%
Non-small Cell Lung Cancer 2.1%
Anxiety 1.8%
Osteoporosis 1.7%
Blood Cholesterol Increased 1.5%
Hypersensitivity 1.4%
Prophylaxis 1.3%
Nausea 1.2%
Vomiting 9.1%
Dyspnoea 8.7%
Pneumonia 7.7%
Drug Ineffective 7.7%
Weight Decreased 7.7%
Weight Increased 6.0%
Wheezing 5.8%
Nausea 5.0%
Death 4.9%
Myocardial Infarction 4.5%
Product Quality Issue 4.4%
Respiratory Failure 3.9%
Vision Blurred 3.8%
Pharmaceutical Product Complaint 3.5%
Tremor 3.5%
Type 2 Diabetes Mellitus 3.4%
Urinary Tract Infection 3.0%
Chronic Obstructive Pulmonary Disease 2.5%
Pain 2.5%
Rash 2.5%
Interacting
Drug Use For Unknown Indication 46.5%
Asthma 14.0%
Hypertension 7.0%
Smoking Cessation Therapy 7.0%
Depression 4.7%
Diabetes Mellitus 4.7%
Pain 4.7%
Atrial Fibrillation 2.3%
Dyspnoea 2.3%
Emphysema 2.3%
Hypercholesterolaemia 2.3%
Hypothyroidism 2.3%
Urinary Tract Infection 28.6%
Bradycardia 14.3%
Nausea 14.3%
Overdose 14.3%
Pulmonary Oedema 14.3%
Wheezing 14.3%